Kiniksa Pharmaceuticals International, plc (KNSA) Net income 2017–2025
Kiniksa Pharmaceuticals International, plc (KNSA) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$59.0MFY2025 · since FY2017: -$64.9M → $59.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $59.0M | +236.6% |
| FY2024 | -$43.2M | -406.7% |
| FY2023 | $14.1M | -92.3% |
| FY2022 | $183.4M | +216.1% |
| FY2021 | -$157.9M | +2.1% |
| FY2020 | -$161.4M | +0.3% |
| FY2019 | -$161.9M | -56.8% |
| FY2018 | -$103.2M | -59.1% |
| FY2017 | -$64.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice